Physician profile
Robert C Rawdin
NPI 1265605828
$9,128.85
in general payments reported to CMS, 2019-2025
14 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $94.03 · 2021: $119 · 2022: $5,055 · 2023: $2,886 · 2024: $412 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,923 · Food and Beverage: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,923.05 |
| Food and Beverage | $1,571.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $3,982.56 | 2022 | |
| Thommen Medical USA, LLC | $3,423.63 | 2021-2023 | |
| Dentsply Sirona INC | $365.04 | 2019-2024 | Waveone Gold Conform Fit, Suresmile, Copal Cavity Varnish |
| Straumann USA LLC | $353.74 | 2019-2022 | |
| Geistlich Pharma, North America, INC. | $211.45 | 2022-2025 | Biomaterials |
| Benco Dental Supply Co. | $188.96 | 2022 | |
| Neoss, INC. | $148.96 | 2021-2024 | Neoss Implant System |
| Zimmer Biomet Holdings, INC. | $133.79 | 2019 | |
| Align Technology, INC. | $122.25 | 2024 | Invisalign |
| Nobel Biocare USA | $76.93 | 2021-2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $38.22 | 2020-2022 | |
| Philips North America LLC | $35.92 | 2020-2022 | |
| Voco America INC. | $25.40 | 2023 | Admira Fusion X-Tra, Voco Retraction Paste, Grandio Blocs |
| Kettenbach Lp | $22.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rawdin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.